1. Neuroinflammation is able to downregulate cytochrome P450 epoxygenases 2J3 and 2C11 in the rat brain.
- Author
-
Navarro-Mabarak C, Loaiza-Zuluaga M, Hernández-Ojeda SL, Camacho-Carranza R, and Espinosa-Aguirre JJ
- Subjects
- Animals, Aryl Hydrocarbon Hydroxylases antagonists & inhibitors, Brain drug effects, Cytochrome P450 Family 2 antagonists & inhibitors, Down-Regulation drug effects, Lipopolysaccharides toxicity, Male, Rats, Rats, Wistar, Steroid 16-alpha-Hydroxylase antagonists & inhibitors, Aryl Hydrocarbon Hydroxylases metabolism, Brain metabolism, Cytochrome P-450 Enzyme System metabolism, Cytochrome P450 Family 2 metabolism, Down-Regulation physiology, Inflammation Mediators metabolism, Steroid 16-alpha-Hydroxylase metabolism
- Abstract
Cytochrome P450 (CYP) epoxygenases have been considered the main producers of epoxyeicosatrienoic acids (EETs) through the oxidation of arachidonic acid (AA). EETs display various biological properties, notably their powerful anti-inflammatory activities. In the brain, EETs have proven to be neuroprotective and to improve neuroinflammation. However, it is known that inflammation could modify CYP expression. We have previously reported that an inflammatory process in astrocytes is able to down-regulate CYP2J3 and CYP2C11 mRNA, protein levels, and activity (Navarro-Mabarak et al., 2019). In this work, we evaluated the effect of neuroinflammation in protein expression of CYP epoxygenases in the brain. Neuroinflammation was induced by the intraperitoneal administration of LPS (1 mg/kg) to male Wistar rats and was corroborated by IL-6, GFAP, and Iba-1 protein levels in the cortex over time. CYP2J3 and CYP2C11 protein levels were also evaluated in the cortex after 6, 12, 24, 48, and 72 h of LPS treatment. Our results show for the first time that neuroinflammation is able to downregulate CYP2J3 and CYP2C11 protein expression in the brain cortex., (Copyright © 2020 Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF